These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

306 related items for PubMed ID: 15121296

  • 1. Pharmaco-economic evaluation of targeted hepatitis A vaccination for children of ethnic minorities in Amsterdam (The Netherlands).
    Postma MJ, Bos JM, Beutels P, Schilthuis H, van den Hoek JA.
    Vaccine; 2004 May 07; 22(15-16):1862-7. PubMed ID: 15121296
    [Abstract] [Full Text] [Related]

  • 2. Cost-effectiveness of routine childhood vaccination for hepatitis A in the United States.
    Rein DB, Hicks KA, Wirth KE, Billah K, Finelli L, Fiore AE, Hoerger TJ, Bell BP, Armstrong GL.
    Pediatrics; 2007 Jan 07; 119(1):e12-21. PubMed ID: 17200237
    [Abstract] [Full Text] [Related]

  • 3. Regional variation in the cost effectiveness of childhood hepatitis A immunization.
    Jacobs RJ, Greenberg DP, Koff RS, Saab S, Meyerhoff AS.
    Pediatr Infect Dis J; 2003 Oct 07; 22(10):904-14. PubMed ID: 14551492
    [Abstract] [Full Text] [Related]

  • 4. An economic analysis of different strategies of immunization against hepatitis A virus in developed countries.
    Das A.
    Hepatology; 1999 Feb 07; 29(2):548-52. PubMed ID: 9918934
    [Abstract] [Full Text] [Related]

  • 5. Cost-utility of universal hepatitis A vaccination in Canada.
    Bauch CT, Anonychuk AM, Pham BZ, Gilca V, Duval B, Krahn MD.
    Vaccine; 2007 Dec 12; 25(51):8536-48. PubMed ID: 17996339
    [Abstract] [Full Text] [Related]

  • 6. The cost-effectiveness of hepatitis A vaccination in patients with chronic hepatitis C viral infection in the United States.
    Arguedas MR, Heudebert GR, Fallon MB, Stinnett AA.
    Am J Gastroenterol; 2002 Mar 12; 97(3):721-8. PubMed ID: 11922569
    [Abstract] [Full Text] [Related]

  • 7. Cost-effective analysis of hepatitis A prevention in Ireland.
    Rajan E, Shattock AG, Fielding JF.
    Am J Gastroenterol; 2000 Jan 12; 95(1):223-6. PubMed ID: 10638588
    [Abstract] [Full Text] [Related]

  • 8. The cost-effectiveness of vaccinating chronic hepatitis C patients against hepatitis A.
    Jacobs RJ, Koff RS, Meyerhoff AS.
    Am J Gastroenterol; 2002 Feb 12; 97(2):427-34. PubMed ID: 11866283
    [Abstract] [Full Text] [Related]

  • 9. Cost-benefit analysis of hepatitis a vaccination in Thailand.
    Teppakdee A, Tangwitoon A, Khemasuwan D, Tangdhanakanond K, Suramaethakul N, Sriratanaban J, Poovorawan Y.
    Southeast Asian J Trop Med Public Health; 2002 Mar 12; 33(1):118-27. PubMed ID: 12118439
    [Abstract] [Full Text] [Related]

  • 10. A cost-effectiveness analysis of universal childhood hepatitis A vaccination in China.
    Zhuang GH, Pan XJ, Wang XL.
    Vaccine; 2008 Aug 18; 26(35):4608-16. PubMed ID: 18597903
    [Abstract] [Full Text] [Related]

  • 11. Effectiveness of a hepatitis A vaccination program for migrant children in Amsterdam, The Netherlands (1992-2004).
    Sonder GJ, Bovée LP, Baayen TD, Coutinho RA, van den Hoek JA.
    Vaccine; 2006 Jun 05; 24(23):4962-8. PubMed ID: 16675076
    [Abstract] [Full Text] [Related]

  • 12. Health economic assessment of universal immunization of toddlers against Hepatitis A Virus (HAV) in Mexico.
    Carlos F, Gómez JA, Anaya P, Romano-Mazzotti L.
    Hum Vaccin Immunother; 2016 Jun 05; 12(1):52-63. PubMed ID: 26503702
    [Abstract] [Full Text] [Related]

  • 13. Cost-effectiveness of universal childhood hepatitis A vaccination in Chile.
    Valenzuela MT, Jacobs RJ, Arteaga O, Navarrete MS, Meyerhoff AS, Innis BL.
    Vaccine; 2005 Jul 14; 23(32):4110-9. PubMed ID: 15964479
    [Abstract] [Full Text] [Related]

  • 14. The cost-effectiveness of hepatitis A vaccination in patients with chronic hepatitis C.
    Myers RP, Gregor JC, Marotta PJ.
    Hepatology; 2000 Apr 14; 31(4):834-9. PubMed ID: 10733536
    [Abstract] [Full Text] [Related]

  • 15. Cost-effectiveness analysis of universal childhood hepatitis A vaccination in Brazil: regional analyses according to the endemic context.
    Sartori AM, de Soárez PC, Novaes HM, Amaku M, de Azevedo RS, Moreira RC, Pereira LM, Ximenes RA, Martelli CM.
    Vaccine; 2012 Dec 14; 30(52):7489-97. PubMed ID: 23107593
    [Abstract] [Full Text] [Related]

  • 16. Testing for antibody to hepatitis A to decrease the cost of hepatitis A prophylaxis with immune globulin or hepatitis A vaccines.
    Bryan JP, Nelson M.
    Arch Intern Med; 1994 Mar 28; 154(6):663-8. PubMed ID: 8129500
    [Abstract] [Full Text] [Related]

  • 17. [Epidemiology and cost-effectiveness analysis of hepatitis A vaccination in Liuzhou City].
    Li X, Xu Z, Hofman A.
    Zhonghua Liu Xing Bing Xue Za Zhi; 1998 Apr 28; 19(2):93-6. PubMed ID: 10322718
    [Abstract] [Full Text] [Related]

  • 18. Efficiency of the incorporation of the hepatitis A vaccine as a combined A+B vaccine to the hepatitis B vaccination programme of preadolescents in schools.
    Navas E, Salleras L, Gisbert R, Dominguez A, Bruguera M, Rodríguez G, Galí N, Prat A.
    Vaccine; 2005 Mar 18; 23(17-18):2185-9. PubMed ID: 15755592
    [Abstract] [Full Text] [Related]

  • 19. Cost effectiveness of hepatitis A/B versus hepatitis B vaccination for US prison inmates.
    Jacobs RJ, Rosenthal P, Meyerhoff AS.
    Vaccine; 2004 Mar 12; 22(9-10):1241-8. PubMed ID: 15003653
    [Abstract] [Full Text] [Related]

  • 20. [Screening policy for travellers from Rotterdam for hepatitis A antibodies prior to eventual immunization: favourable cost-benefit ratio].
    Reintjes R, Bosman A, de Zwart O.
    Ned Tijdschr Geneeskd; 1999 Aug 28; 143(35):1777-80. PubMed ID: 10494329
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.